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MiR-140 is a microRNA specially involved in chondrogenesis and osteoarthritis pathogenesis. How-
ever, its transcriptional regulation and target genes in cartilage development are not fully under-
stood. Here we detected that miR-140 was uniquely expressed in chondrocyte and suppressed by
Wnt/b-catenin signalling. The miR-140 primary transcript was an intron-retained RNA co-expressed
with Wwp2-C isoform, which was directly induced by Sox9 through binding to the intron 10 of
Wwp2 gene. Knockdown of miR-140 in limb bud micromass cultures resulted in arrest of chondro-
genic proliferation. Sp1, the activator of the cell cycle regulator p15INK4b, was identiﬁed as a target of
miR-140 in maintaining the chondrocyte proliferation. Collectively, our ﬁndings expand our under-
standing of the transcriptional regulation and the chondrogenic role of miR-140 in chondrogenesis.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Cartilage and bone are composed of chondrocytes and osteo-
blasts that differentiate from common mesenchymal progenitors
[1]. Recent evidence has shown that Wnt/b-catenin signalling
determines whether these progenitors will differentiate into chon-
drogenic or non-chondrogenic cells [1,2]. Thereafter, chondrocyte
differentiation is mainly regulated by the transcriptional factor
Sox9, which diminishes b-catenin levels in the chondrogenic pro-
genitors [3,4]. The population of mesenchymal progenitor cells is
maintained by Wnt/b-catenin signalling in the superﬁcial layer of
postnatal articular cartilage [2,5]. The hallmarks of osteoarthritis
(OA) include the loss of these progenitors and premature chondro-
cyte differentiation [6]. Thus, elucidating the cellular mechanisms
underlying the maintenance and differentiation of those mesen-
chymal progenitors is important for OA treatment. The analysis
of the differentiation of the progenitors into chondrogenic andchemical Societies. Published by E
ilding 1, Shanghai Jiao Tong
ople’s Republic of China. Fax:Wnt-induced non-chondrogenic cells will allow for the identiﬁca-
tion of speciﬁc chondrogenic modulators through comparative
proﬁling.
MicroRNAs (miRNAs), which are a class of short (20–23 nt) non-
coding RNAs, are generated from primary transcripts (pri-miRNAs)
by Drosha and Dicer enzymes and target speciﬁc mRNAs through
the formation of RNA-induced silencing complexes (RISCs) [7].
Some microRNAs have recently been reported to play important
roles in chondrogenesis and the pathogenesis of osteoarthritis
[8–11]. Among those miRNAs, miR-140 is exclusively expressed
in cartilage, and its null mutant exhibits OA symptoms [10].
MiR-140 is known to be involved in the aetiology of OA and is
being considered as a potential therapeutic target. However, its
transcriptional regulation and the target network that is involved
in the chondrogenic process are not fully understood.
In our study, miRNA comparative proﬁling revealed that
miR-140 was uniquely expressed in chondrogenesis. It was found
to be derived from an intron-retained transcript and share overlap-
ping expression patterns with Sox9 and ColII. MiR-140 was co-tran-
scribed with a C-terminal isoform of its host gene, Wwp2, and
directly induced by the chondrogenic transcription factor Sox9.
In addition, miR-140 sustained chondrocyte proliferation by inhib-
iting Sp1 protein expression. Collectively, our results shed new
light on the mechanisms of miR-140 in chondrogenesis.lsevier B.V. All rights reserved.
Fig. 1. Chondrocyte-speciﬁc microRNAs were identiﬁed through comparative proﬁling of micromass cultures with or without Wnt3a/LiCl induction. (A) Schedule of
microRNAs collection from the chondrogenic and non-chondrogenic micromass cultures. (B and C) The effects of different concentrations of LiCl- or Wnt3a-conditioned
medium on the chondrogenesis of the micromass cultures were evaluated. Both 15 mM LiCl (B) and 2 Wnt3a medium (C) were sufﬁcient to induce non-chondrogenic
differentiation. (D) 46 microRNAs were activated during chondrogenesis as shown by comparative proﬁling that was conducted on the ﬁrst and ﬁfth day of cultures. (E) The
top differentially expressed microRNAs between the chondrogenic and non-chondrogenic cultures are presented.
Fig. 2. The miR-140/140⁄ primary transcript is co-expressed with the Wwp2-C gene in chondrocytes. (A) RT-PCR showing the expression of the miR-140/140⁄ primary
transcript (Lane 1), exons 16–17 of Wwp2 (lower band in Lane 4) and intron-retained miR-140/140⁄ primary transcript (upper band in Lane 4). Lanes 2, 5: Non-RT control.
Lanes 3, 6: DNA positive control. (B) 5’-RACE and 3’-RACE of the miR-140/140⁄ primary transcript from mouse limb buds at E12.5. (C) Semi-quantitative RT-PCR revealed that
the miR-140/140⁄ primary transcript was much less abundant than the Wwp2 spliced transcript. Lane 1: product from exon16 – exon 17, Lane 2: product from exon 15 –
intron 16. (D) Whole mount in situ hybridisation using different probes in limb buds at E12.5. (E) The Wwp2-C protein was detected in the limb bud extraction at E12.5. The
lysates of the 293T cells transfected with the Wwp2-C-his plasmid were used as positive controls.
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Fig. 3. Sox9 directly induces the expression of miR-140. (A) Knockdown of Sox9 expression in ATDC5 cells by ShRNA. (B) Mature miR-140 expression levels diminished
following the loss of Sox9 expression. (C) Sox9 induced luciferase activity in the reporter ligated to the -2 kb promoter of the miR-140 primary transcript in ATDC5 cells. (D)
Sox9 induced luciferase activity in a dose-dependent manner in 293T cells. (E) Sox9 induced the expression of mature miR-140 in the ATDC5 cell lines as indicated by Q-PCR.
MiR-22 was used as the control. (F) Two Sox9 binding sites were identiﬁed in the -2 kb upstream region of the miR-140 primary transcript. Mutagenesis in the putative
binding site 2 abrogated the induction activity of Sox9 in both the 293T and ATDC5 cells. (G) Sox9-binding site 2 (-200 bp) was veriﬁed by ChIP in limb buds at E12.5 using the
anti-Sox9 antibody. (H) Wnt3a suppressed the expression of Sox9 in micromass cultures. (I) The induction of Sox9 in miR-140 promoter was downregulated by Wnt3a in
ATDC5 cells. Data are presented as means ± S.D. (n = 3; ⁄P < 0.05).
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2.1. DNA constructs
The plasmids, including the Sox9 shRNA, miR-140 sponge and
luciferase reporters, were constructed as described in Supplemen-
tary Materials and Methods.
2.2. Micromass cultures, cell lines and experiments
The protocols used for the cell culturing, transfections, lucifer-
ase assay, Western blot, cell proliferation and cell cycle analyses
are indicated in Supplementary Materials and Methods.
2.3. MicroRNA extraction, microarray analysis and quantitative PCR
The microRNA extraction, microarray analysis and quantitative
PCR were conducted as described in Supplementary Materials and
Methods.
2.4. RT-PCR, RACE
The RNA was extracted and analysed by RT-PCR or RACE exper-
iments as described in Supplementary Materials and Methods.2.5. Chromatin immunoprecipitation (ChIP) experiment
E12.5 limb bud cells were ﬁxed with 37% formaldehyde for
10 min, followed by 10 rounds of 10-s sonications to fragment
the chromatin. The chromatin was incubated with the anti-Sox9
antibody (ab3697, Abcam) at 4 C overnight and immunoprecipi-
tated with protein A/G Sepharose (Santa Cruz) the next day. Puri-
ﬁed DNA was ampliﬁed by PCR using primer pairs that spanned
the predicted Sox9 binding sites. Primers are listed in Supplemen-
tary Table S1.
2.6. Whole mount in situ hybridisation
The probes were labelled using the DIG RNA Labelling Kit
(Roche). E12.5 embryos were dissected in PBS, ﬁxed in 4% parafor-
maldehyde at 4 C and processed as described previously [12].
2.7. Generation of RCAS::EGFP-miR140-Sponge virus
The EGFP-miR-140-Sponge DNA sequence was ampliﬁed by
PCR and cloned into the RCAS-Y DV vector as described previ-
ously [13]. The RCAS::EGFP-miR-140-Sponge virus was collected
from transfected chicken embryonic ﬁbroblasts as described pre-
viously [14].
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3.1. Identiﬁcation of chondrogenic microRNAs by comparative
proﬁling of chondrogenic and non-chondrogenic cultures
To identify the chondrogenic microRNAs, we compared the
expression proﬁles of the microRNAs from the chondrogenic and
non-chondrogenic cultures. Micromass cultures from limb buds
at E12.5 were grown in condition that mimicked chondrogenic dif-
ferentiation, while non-chondrogenic differentiation was stimu-
lated by the induction of Wnt3a or LiCl. The microRNAs were
collected from the samples at 2 h and on days 1 and 5 from the
micromass cultures (Fig. 1A). Alcian blue staining of the micromass
cultures showed that both Wnt3a and 15 mM LiCl were sufﬁcient
to cause the mesenchymal progenitors to differentiate into non-
chondrogenic cells (Fig. 1B and C). The Wnt3a or LiCl stimulation
exerted similar effects on the behaviours of microRNAs in the
non-chondrogenic cultures (Supplementary Fig. S1).
According to the results of the comparative microRNA proﬁling,
46 microRNAs were activated during chondrogenesis after 5 days
(Fig. 1D). However, only three major microRNAs (miR-140, miR-
140⁄ and miR-455) were signiﬁcantly inhibited by Wnt3a and LiCl
induction during non-chondrogenic differentiation (Fig. 1E).
Conversely, some microRNAs (miR-1, miR-133a, miR-133b and
miR-206) with muscle-related signatures [15,16], exhibited oppo-
site responses to Wnt stimulation (Fig. 1E and SupplementaryFig. 4. MiR-140 knockdown impairs chondrogenesis by inhibiting chondrocyte prol
construction of the miR-140 overexpression and the miR-140-Sponge vectors. (B) pEGFP-
was signiﬁcantly relieved by pEGFP-miR-140-Sponge. (C) Sox9 suppressed the lucifera
eliminated by pEGFP-miR-140-Sponge. (D) RCAS::EGFP-miR-140-Sponge virus suppress
Alcian blue and Alizarin red staining. (E) In situ hybridisation using ColII probe on the m
incorporation was quantiﬁed using the anti-BrdU antibody on day 3 in micromass cultur
140-Sponge blocked the chondrogenesis that was induced by BMP2 in the micromass cu
on days 3 and 5 on the micromass cultures revealed that the RCAS::EGFP-miR-140-Spon
those of Sox9 and ColII. Data are presented as means ± S.D. (n = 3; ⁄P < 0.05).Fig. S2). This supports the belief that the activation ofWnt signalling
is able to convert chondrogenic cells into thosedestined to formcon-
nective tissue that sustains myogenesis [17]. Therefore, miR-140
and miR-140⁄ could be regarded as chondrocyte-speciﬁc markers
that respond oppositely to muscle-related microRNAs during Wnt
signalling stimulation.
3.2. miR-140/140⁄ Primary transcript is co-expressed with the C-
terminal isoform of the Wwp2 gene in chondrogenesis
MiR-140 was exclusively involved in chondrogenesis and nearly
absent in non-chondrogenic processes as was conﬁrmed by real-
time PCR (Supplementary Fig. S3). The precursor miR-140 is lo-
cated in intron 16 of the Wwp2 gene. RT-PCR results showed that
miR-140/140⁄ primary transcript was co-expressed with the
Wwp2 gene as an intron-retained transcript (Fig. 2A). The RACE
analyses indicated that the miR-140/140⁄ primary transcript ex-
tended from intron 10 to the middle of exon 24 in the Wwp2 gene
(Fig. 2B). However, the intron-retained miR-140/140⁄ primary
transcript was less abundantly expressed with respect to the
Wwp2 transcript (Fig. 2C). The whole mount in situ hybridisation
also revealed that the miR-140/140⁄ primary transcript was clearly
expressed in the chondrogenic region (Sox9 and ColII markers rep-
resented) and was excluded from non-chondrogenic joint region
(Gdf5 marker represented). Similar expression was detected by
probes that covered the 30 CDS and 30 UTR of Wwp2 (Fig. 2D).iferation in limb bud micromass cultures. (A) Schematic diagram showing the
Pri-miR-140 suppressed the luciferase activity of pGL3-miR-140B, and the inhibition
se activity of pGL3-miR-140B (20%) in 293T cells, and the suppression was also
ed chondrogenesis in limb bud micromass cultures on day 4 as was indicated by
icromass cultures on days 3 and 5. RCAS probe was used as the control. (F) BrdU
es. Central and peripheral areas are indicated as boxes in (D). (G) RCAS::EGFP-miR-
ltures. (H) The G1/S and G2/S ratios in the cell cycle are indicated. (I) Q-PCR analysis
ge virus increased the expression levels of p15INK4b and p21Waf1/Clip1 and decreased
2996 J. Yang et al. / FEBS Letters 585 (2011) 2992–2997The Wwp2 gene has three isoforms, the full-length Wwp2-FL, N-
terminal Wwp2-N and C-terminal Wwp2-C [18]. Surprisingly, the
Wwp2-N and Wwp2-FL transcripts were barely detectable in chon-
drocytes (Fig. 2D). The western blot also detected the abundant
expression of the Wwp2-C protein in chondrocytes from limbs
buds using an antibody against ‘‘QEPALPPGWEMK’’ (Fig. 2E). This
indicates that the Wwp2-C isoform is abundantly expressed in
chondrocytes, and Wwp2-N and Wwp2-FL are absent. Taken to-
gether, these data suggest that miR-140 is intron-derived and co-
expressed with the host Wwp2-C gene.
3.3. Sox9 directly induces the expression of miR-140
The exclusive expression of the miR-140 primary transcript in
chondrocytes raises the possibility thatmiR-140 is transcriptionally
regulated by Sox9. To address this possibility, a Sox9 knockdown
was created using shRNA in ATDC5 cells, which resulted in reduced
miR-140 expression (Fig. 3A and B). This is consistent with the pre-
vious report that described that the deletion of Sox9 diminishes the
expression of miR-140 [10]. Using a luciferase reporter that was
fused to the upstream region (2000 bp) of the miR-140 primary
transcript, we observed that Sox9 strongly stimulated luciferase
activity in ATDC5 and 293T cells (>5-fold) (Fig. 3C and D). In the
ATDC5 cells, Sox9 also signiﬁcantly induced the production of ma-
ture miR-140 (4-fold) (Fig. 3E). Two presumptive Sox9 binding
sites (CAGGCTTCCTTTGT at 824 bp and TAAAGGTGCTTTGT at
200 bp) in the upstream region of the miR-140 primary transcript
were mutated individually in the pGL3-miR-140 promoter vector
(Fig. 3F). The mutation of binding site 2 signiﬁcantly impaired the
luciferase activity that was induced by Sox9 (Fig. 3F). The ChIP anal-
ysis also documented the direct binding of Sox9 in the promoter re-
gion of themiR-140 primary transcript (Fig. 3G). In addition,Wnt3a
stimulation downregulated Sox9 expression during chondrogenesis
in themicromass cultures and impaired the induction of Sox9 in the
promoter of miR-140 in the ATDC5 cell line (Fig. 3H and I). The
suppression of miR-140 by Wnt/b-catenin is partially due to theFig. 5. Sp1 is a target of miR-140 in chondrocyte proliferation. (A) Schematic map of the
Sp1 expression was elevated in the micromass cultures that were infected with RCAS::EG
as the control. (C) The Sp1mRNA did not signiﬁcantly change in micromass cultures follow
luciferase activity of pGL3-Sp1-UTR in a dose-dependent manner in 293T cells. (E) pEGFP-
Sp1 mRNA was unchanged in response to the overexpression of pEGFP-Pri-miR-140. (G)
140 on pGL3-Sp1-UTR. Mutations are indicated in (A). (H) The p15INK4b mRNA was signiﬁc
transfected with pN3-Sp1 was suppressed compared to that of the control. Data are preinhibition of Sox9 by Wnt stimulation. Collectively, these experi-
ments indicate that the miR-140 is directly induced by Sox9 during
chondrogenesis.
3.4. MiR-140 sustains chondrocyte proliferation
To further decipher the role of miR-140 in chondrogenic differ-
entiation, an EGFP-miR-140-Sponge strategy was developed to
knockdown miR-140 expression (Fig. 4A). A luciferase reporter
pGL3-miR-140B was constructed by inserting one miR-140 binding
site into the pGL3-promoter vector. In 293T cells, pEGFP-miR-140-
Sponge demonstrated the ability to release the suppression of
pGL3-miR-140B luciferase activity by pEGFP-Pri-miR-140 or Sox9
(Fig. 4B and C). The chondrogenesis of limb bud micromass cul-
tures was obviously blocked by RCAS::EGFP-miR-140-Sponge virus
infection with respect to the control virus RCAS::EGFP as shown by
Alcian blue and Alizarin red staining and ColII expression (Fig. 4D
and E). The impairment of chondrogenesis was much more severe
in the centre of the micromass compared to the periphery (Fig. 4D).
However, this asymmetric defect of chondrogenesis resulted from
the impairment of chondrocyte proliferation but not from chon-
drocyte differentiation as was revealed by the expression of ColII
and BrdU incorporation (Fig. 4E and F). The sponge virus also
blocked the induction of chondrogenesis by BMP2 in the micro-
mass cultures (Fig. 4G). These ﬁndings indicate that miR-140
regulates chondrogenesis in part by maintaining chondrocyte
proliferation.
To understand how miR-140 regulated cell proliferation, a cell
cycle analysis was performed on the micromass cultures. Our re-
sults showed the knockdown of miR-140 by the sponge virus ar-
rested the cells in the G1 (approximately 1.4-fold) and G2 states
(approximately 1.3-fold) (Fig. 4H). Furthermore, the miR-140
knockdown greatly increased the expression of the cell cycle regu-
lator p15INK4b (>2-fold) and diminished Sox9 and ColII expression
(Fig. 4I). Thus, miR-140 regulates chondrogenic proliferation in
part via the inhibition of p15INK4b.location of miR-140 binding sites in Sp1 30 UTR. (B) Western blot indicated that the
FP-miR-140-Sponge compared to those infected with RCAS::EGFP. GAPDH was used
ing RCAS::EGFP-miR-140-Sponge exposure. (D) pEGFP-Pri-miR-140 suppressed the
Pri-miR-140 downregulated the expression of endogenous Sp1 in 293T cells. (F) The
Mutations in the miR-140 binding sites released the suppression of pEGFP-Pri-miR-
antly activated by the overexpression of Sp1. (I) The proliferation of ATDC5 that was
sented as means ± S.D. (n = 3; ⁄P < 0.05).
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Recent studies suggest that Smad3 is a target of miR-140 [19].
However, based on Smad3 protein expression and luciferase repor-
ter assays of the miR-140 knockdown, Smad3 was excluded as a
direct target of miR-140 in chondrocyte proliferation (Supplemen-
tary Fig. S4). The online database DIANA-microT-4.0 (http://diana.c-
slab.ece.ntua.gr/pathways/) showed that another potential target of
miR-140, Sp1, contained twomiR-140binding sites in its 30 UTRwith
7-mer seeds (Fig. 5A). Sp1 was previously reported to be expressed
in chondrocytes to activate the expression ofColII [20,21] and is also
regarded to be a critical transcription factor in the inhibition of the
cell cycle via the activation of the p15INK4b and p21Waf1/Clip promot-
ers in vitro [22–24]. The western blot revealed that Sp1 protein lev-
els were obviously increased in the miR-140 knockdown (Fig. 5B),
while Sp1 mRNA levels did not signiﬁcantly change (Fig. 5C). The
luciferase reporter pGL3-Sp1-UTR, which harbouredmiR-140 bind-
ing sites, was repressed by the co-transfection of pEGFP-Pri-miR-
140 compared to the control in 293T cells (Fig. 5D). Endogenous
Sp1 protein expression was also suppressed by the overexpression
of miR-140, while its mRNA levels remained unchanged (Fig. 5E
and F). This suppression could be released by mutations in miR-
140 binding sites in the Sp1 30 UTR domain (Fig. 5G). In addition,
p15INK4b mRNA was signiﬁcantly activated and cell proliferation
wasdownregulatedby theenforcedexpressionof Sp1 inATDC5cells
(Fig. 5H and I). Thus, these results indicate that Sp1 is a target ofmiR-
140andpartially accounts for the ability ofmiR-140 to sustain chon-
drocyte proliferation.
In summary, our ﬁndings expand current insights into themech-
anisms of miR-140 in the regulation of chondrogenesis. MiR-140
regulates chondrocyte proliferation partially by repressing Sp1, act-
ing downstream of Bmp2 signalling to promote chondrogenesis. It
has been previously reported that miR-140 targets Adamts-5 and
HDAC4 to regulate chondrocyte differentiation [10,25]. Considering
these ﬁndings, miR-140 seems to modulate chondrocyte differenti-
ation by targeting Adamts-5 and HDAC4, while it regulates chon-
drocyte proliferation by repressing Sp1 activity.
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